Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 19
2013 5
2014 17
2015 24
2016 22
2017 11
2018 4
2019 4
2020 7
2021 3
2022 5
2023 5
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 31644210

100 results

Results by year

Filters applied: . Clear all
Page 1
Vorapaxar.
[No authors listed] [No authors listed] 2017 Apr 11. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Apr 11. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644210 Free Books & Documents. Review.
Vorapaxar in the treatment of cardiovascular diseases.
Tantry US, Bliden KP, Chaudhary R, Novakovic M, Rout A, Gurbel PA. Tantry US, et al. Future Cardiol. 2020 Sep;16(5):373-384. doi: 10.2217/fca-2019-0090. Epub 2020 Apr 20. Future Cardiol. 2020. PMID: 32308016 Free PMC article.
Vorapaxar in the secondary prevention of atherothrombosis.
Tantry US, Liu F, Chen G, Gurbel PA. Tantry US, et al. Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1293-305. doi: 10.1586/14779072.2015.1109447. Epub 2015 Nov 12. Expert Rev Cardiovasc Ther. 2015. PMID: 26559689 Review.
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.
Scirica BM, Bonaca MP, Braunwald E, De Ferrari GM, Isaza D, Lewis BS, Mehrhof F, Merlini PA, Murphy SA, Sabatine MS, Tendera M, Van de Werf F, Wilcox R, Morrow DA; TRA 2°P-TIMI 50 Steering Committee Investigators. Scirica BM, et al. Lancet. 2012 Oct 13;380(9850):1317-24. doi: 10.1016/S0140-6736(12)61269-0. Epub 2012 Aug 26. Lancet. 2012. PMID: 22932716 Clinical Trial.
100 results